Bifeprunox (DU-127090) is a novel atypical antipsychotic agent which along with SLV313 aripiprazole and SSR-181507 combines minimal D2 receptor agonism with 5-HT receptor agonism.Bifeprunox has a novel mechanism of action. Conventional antipsychotics are classed into typical and atypical. The typical antipsychotics such as chlorpromazine and haloperidol are potent D2 receptor antagonists.
This page contains content from the copyrighted Wikipedia article "Bifeprunox"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
